BriaCell Therapeutics Corp logo

BriaCell Therapeutics Corp

NEW
TSX:BCT (Canada)   Ordinary Shares - New
C$ 4.82 -0.28 (-5.49%) Jul 31
At Loss
P/B:
1.06
Market Cap:
C$ 41.93M ($ 29.91M)
Enterprise V:
C$ 9.09M ($ 6.48M)
Volume:
2.44K
Avg Vol (2M):
6.56K
Trade In:
Volume:
2.44K
At Loss

BriaCell Therapeutics Corp (TSX:BCT) Dividend

BriaCell Therapeutics Corp (TSX:BCT) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -163.5%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: TSX:BCT Dividend

Does BriaCell Therapeutics Corp (TSX:BCT) pay a dividend?

BriaCell Therapeutics Corp (TSX:BCT) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't BriaCell Therapeutics Corp pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. BriaCell Therapeutics Corp has returned capital to shareholders via buybacks at a rate of -163.5% over the past 3 years.

What are dividend-paying alternatives to BriaCell Therapeutics Corp?

For dividend-paying alternatives in BriaCell Therapeutics Corp's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.